Literature DB >> 354685

Immune complexes in myelofibrosis: a possible guide to management.

C M Lewis, G D Pegrum.   

Abstract

Using a fluorescent technique intracellular immune complexes were found in the peripheral leucocytes in all of 12 patients with myelofibrosis studied. Fluorescent cells varied from 12% to 81%; with no relation to the total white count or any obvious clinical finding. Three of the patients with severe refractory anaemia benefited from immunosuppressive therapy.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 354685     DOI： 10.1111/j.1365-2141.1978.tb01093.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  9 in total

1.  Monoclonal gammopathy in chronic myeloproliferative disorders.

Authors:  T Economopoulos; J Economidou; E Papageorgiou; J Dervenoulas; C Christodoulides; V Pappa; D Karakassis; C Terzoglou; S Athanassiadou; G Chalevelakis
Journal:  Blut       Date:  1989-01

2.  Circulating high molecular weight IgG fibronectin complexes in myeloproliferative disorders.

Authors:  T P Baglin; S M Price; B J Boughton
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

3.  Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)--correlations between clinical and morphological features.

Authors:  J Thiele; B Hoeppner; R Zankovich; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 4.  An immune dysregulation in MPN.

Authors:  Giovanni Barosi
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

5.  Composition of immune complexes and their relation to plasma fibronectin in chronic myeloproliferative disorders.

Authors:  T P Baglin; A W Simpson; S M Price; B J Boughton
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

6.  Immune abnormalities in myelodysplastic syndromes.

Authors:  T Economopoulos; J Economidou; G Giannopoulos; C Terzoglou; E Papageorgiou; J Dervenoulas; P Arseni; J Hadjioannou; S Raptis
Journal:  J Clin Pathol       Date:  1985-08       Impact factor: 3.411

7.  Immune derangements in patients with myelofibrosis: the role of Treg, Th17, and sIL2Rα.

Authors:  Jen C Wang; Hemant Sindhu; Chi Chen; Ajay Kundra; Muhammad I Kafeel; Ching Wong; Stephen Lichter
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

8.  Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation.

Authors:  Charlotte Liisborg; Vibe Skov; Lasse Kjær; Hans Carl Hasselbalch; Torben Lykke Sørensen
Journal:  EClinicalMedicine       Date:  2021-12-25

Review 9.  MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives.

Authors:  Hans Carl Hasselbalch; Mads Emil Bjørn
Journal:  Mediators Inflamm       Date:  2015-10-28       Impact factor: 4.711
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.